Sweden vs United States of America: Treatment success rate for patients treated for MDR-TB
Sweden
87.0%
in 2022
United States of America
87.0%
in 2021
Sweden rank
27th
United States of America rank
27th
Treatment success rate for patients treated for MDR-TB over time
- Sweden
- United States of America
How they compare
Sweden currently reports 87.0% against 87.0% in United States of America, a difference of 0.0%.
The two have swapped places 6 times across 16 shared years of data; in 2006 it was Sweden ahead.
Sweden ranks 27th and United States of America ranks 27th of 163 countries.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Sweden | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 89.0% | 71.8% | 17.2% | Sweden |
| 2010s | 89.0% | 74.9% | 14.1% | Sweden |
| 2020s | 91.5% | 83.5% | 8.0% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Sweden or United States of America?
- Sweden, at 87.0% against 87.0% in United States of America as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Sweden and United States of America?
- 0.0%, with Sweden ahead.
- How many years of comparable data are there for Sweden and United States of America?
- 16 years are reported by both, from 2006 to 2021.
- How do Sweden and United States of America rank globally for treatment success rate for patients treated for mdr-tb?
- Sweden ranks 27th and United States of America ranks 27th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.